CAS Sex- and Gender-Specific Medicine
Both biology (sex) and sociocultural variables (gender) have a fundamental impact on health behaviour, as well as epidemiology, manifestation, and pathophysiology of diseases. Although sex and gender are essential to effective health care, differences between women and men are often neglected in medical research and clinical practice. The CAS study programme in Sex- and Gender-specific Medicine is a part-time course for postgraduates at the Universities of Bern and Zurich. The CAS will start in March 2021 and is now open for applications.
Cathérine Gebhard was the founding president of the commission on Sex and Gender in Medicine (SGiM) at the University of Zurich from 2017-2022. The commission was founded in 2015 by the Vice President Medicine of the University of Zurich Prof. Beatrice Beck Schimmer and aims to promote the implementation of gender-specific medicine in medical education, research, and clinical practice at the University of Zurich (CH). In November 2019, the SGiM commission has hosted the Kick off Symposium «Chances and Perspectives of Gender Medicine» at the Aula of the University of Zurich.
Vera Regitz Zagrosek
In 2019, Vera Regitz Zagrosek, a pioneer in Gender Medicine and founder of the Gender Institute at Charité Berlin has joined the University of Zurich as part of the Anna Fischer Dückelmann Visiting Professorship. Vera helps to translate Gender Medicine into clinical practice and is actively participating in research projects of our group.
Master students and doctoral students
We believe in translational research as the interface between pre-clinical and clinical science, and put a strong focus on state-of-the-art imaging technologies and molecular biology. Over the past years, we have seen growing interest from bachelor, master, and doctoral students. Joining the Gebhard Lab means a chance to complete research projects and theses in an interdisciplinary and collaborative environment. We welcome enquires from prospective students.
Our research is conducted in close collaboration with the Department of Nuclear Medicine, USZ (clinical research), the Institute of Pharmaceutical Sciences, ETHZ (pre-clinical imaging), and the Center for Molecular Cardiology, UZH (molecular biology). Multicenter studies are currently conducted in collaboration with the University Hospital Basel, the Inselspital Berne, and the Cantonal Hospital Baden.
Currently we do not have any open positions.